[1]
2023. IMMUNOGENICITY OF A HETEROLOGOUS INACTIVATED AND mRNA COVID-19 COMBINATION VACCINE REGIMEN: heterologous inactivated and mRNA COVID-19 vaccine regimen. The Southeast Asian Journal of Tropical Medicine and Public Health. 54, 4 (Jul. 2023), 167–181.